Latest filing published 23 Feb 2026 for Adma Biologics, INC., €90k.
Filing timeline
BuySaleInsider track record
Brad L. Tade: trading record in brief
Brad L. Tade is a declared insider of Adma Biologics, Inc., with filings sourced from SEC (Form 4). The record holds 7 filings, for trades running from 24 July 2024 to 19 February 2026.
On the market, this insider has only sold: 1 sale, €303k in total. The rest of the record consists of 6 share grants.
On 23 February 2026 came the latest disclosure, a share grant for €90k in Adma Biologics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Brad L. Tade
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,479 shares@ US$16.3212.3% of flowCommon StockSEC:0001140361-26-006460:0
- 7,123 shares@ US$17.3114.3% of flowCommon StockSEC:0001140361-25-027641:0
- 9,838 shares@ US$18.4021.2% of flowCommon StockSEC:0001140361-25-024252:0
- 5,280 shares@ US$15.7810.8% of flowCommon StockSEC:0001140361-25-006384:0
- 62,227 shares0Common StockSEC:0001140361-25-005536:0
- 15,000 shares@ US$21.1541.4% of flowCommon StockSEC:0001140361-24-047702:0
- 72,400 shares0Common StockSEC:0001140361-24-034471:0
7 of 7 declarations
